Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Sutro Biopharma Total Assets 2017-2019 | STRO

Sutro Biopharma total assets from 2017 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  
Sutro Biopharma Annual Total Assets
(Millions of US $)
2018 $223
2017 $41
2016 $69
Sutro Biopharma Quarterly Total Assets
(Millions of US $)
Q3 2019 $172
Q2 2019 $189
Q1 2019 $202
Q4 2018 $223
Q3 2018 $145
Q2 2018 $0
Q1 2018 $0
Q4 2017 $0
Q3 2017 $0
Q4 2016 $69
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.258B $0.038B
Sutro Biopharma Inc. develops and manufactures pharmaceutical products. The Company provides antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy. Its product pipeline consists of STRO-001 and STRO-002 which are in clinical stage. Sutro Biopharma Inc. is based in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $138.308B 15.93
CSL (CSLLY) Australia $85.405B 0.00
Gilead Sciences (GILD) United States $83.588B 10.36
Vertex Pharmaceuticals (VRTX) United States $56.863B 58.04
Biogen (BIIB) United States $52.454B 9.00
Illumina (ILMN) United States $47.477B 52.09
Regeneron Pharmaceuticals (REGN) United States $40.493B 17.73
Alexion Pharmaceuticals (ALXN) United States $25.238B 12.46
Seattle Genetics (SGEN) United States $20.383B 0.00
Incyte (INCY) United States $20.269B 47.05
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.624B 0.00
Genmab (GNMSF) Denmark $14.513B 64.10
BioMarin Pharmaceutical (BMRN) United States $14.411B 0.00
Alnylam Pharmaceuticals (ALNY) United States $13.643B 0.00
Galapagos (GLPG) Belgium $11.053B 28.48
Exact Sciences (EXAS) United States $10.807B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
BeiGene (BGNE) Cayman Islands $9.600B 0.00
QIAGEN (QGEN) Netherlands $9.593B 31.28
Sarepta Therapeutics (SRPT) United States $8.297B 0.00
Bio-Techne Corp (TECH) United States $8.214B 54.98
Amarin (AMRN) Ireland $7.727B 0.00
Moderna (MRNA) United States $7.092B 0.00
Guardant Health (GH) United States $7.062B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.922B 0.00
Medicines (MDCO) United States $6.705B 0.00
Reata Pharmaceuticals (RETA) United States $6.134B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.042B 15.36
ARGENX SE-ADR (ARGX) Netherlands $5.609B 0.00
Exelixis (EXEL) United States $5.065B 14.25
Ascendis Pharma (ASND) Denmark $4.793B 0.00
Bluebird Bio (BLUE) United States $4.696B 0.00
China Biologic Products (CBPO) China $4.597B 25.90
Repligen (RGEN) United States $4.570B 82.82
Spark Therapeutics (ONCE) United States $4.272B 0.00
Mirati Therapeutics (MRTX) United States $4.133B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.037B 0.00
MorphoSys AG (MOR) Germany $3.985B 0.00
Blueprint Medicines (BPMC) United States $3.775B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.728B 0.00
Immunomedics (IMMU) United States $3.674B 0.00
Adaptive Biotechnologies (ADPT) United States $3.353B 0.00
Alkermes (ALKS) Ireland $3.191B 0.00
Genmab (GMAB) Denmark $3.064B 6.31
MyoKardia (MYOK) United States $3.029B 0.00
UniQure (QURE) Netherlands $2.788B 0.00
Emergent Biosolutions (EBS) United States $2.770B 27.52
Halozyme Therapeutics (HALO) United States $2.739B 0.00
Amicus Therapeutics (FOLD) United States $2.737B 0.00
NeoGenomics (NEO) United States $2.670B 142.06
Acceleron Pharma (XLRN) United States $2.593B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.401B 0.00
Zai Lab (ZLAB) China $2.354B 0.00
Arena Pharmaceuticals (ARNA) United States $2.301B 5.35
RA PHARMCTL INC (RARX) United States $2.215B 0.00
Insmed (INSM) United States $2.052B 0.00
Ligand Pharmaceuticals (LGND) United States $1.950B 37.50
Myriad Genetics (MYGN) United States $1.843B 27.23
Dicerna Pharmaceuticals (DRNA) United States $1.771B 0.00
Denali Therapeutics (DNLI) United States $1.702B 0.00
Zymeworks (ZYME) Canada $1.695B 0.00
REGENXBIO (RGNX) United States $1.638B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.634B 0.00
Akcea Therapeutics (AKCA) United States $1.623B 0.00
Editas Medicine (EDIT) United States $1.554B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.520B 0.00
Epizyme (EPZM) United States $1.448B 0.00
Alector (ALEC) United States $1.340B 0.00
Sangamo Therapeutics (SGMO) United States $1.318B 0.00
Innoviva (INVA) United States $1.314B 3.87
Arvinas (ARVN) United States $1.271B 0.00
Athenex (ATNX) United States $1.239B 0.00
Coherus BioSciences (CHRS) United States $1.226B 0.00
WAVE Life Sciences (WVE) Singapore $1.169B 0.00
Principia Biopharma (PRNB) United States $1.156B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.141B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
Fate Therapeutics (FATE) United States $1.067B 0.00
Zealand Pharma (ZEAL) Denmark $0.974B 0.00
Revance Therapeutics (RVNC) United States $0.909B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.908B 7.64
ZIOPHARM Oncology Inc (ZIOP) United States $0.889B 0.00
Codexis (CDXS) United States $0.888B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.870B 0.00
Precision BioSciences (DTIL) United States $0.856B 0.00
Pharming Group (PHGUF) Netherlands $0.840B 0.00
Vericel (VCEL) United States $0.836B 311.83
Intellia Therapeutics (NTLA) United States $0.834B 0.00
Anika Therapeutics (ANIK) United States $0.812B 26.34
MiMedx (MDXG) United States $0.797B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.792B 0.00
Twist Bioscience (TWST) United States $0.748B 0.00
Heska (HSKA) United States $0.746B 190.58
ANI Pharmaceuticals (ANIP) United States $0.720B 12.27
Adverum Biotechnologies (ADVM) United States $0.691B 0.00
DBV Technologies S.A (DBVT) France $0.688B 0.00
Cara Therapeutics (CARA) United States $0.678B 0.00
UROGEN PHARMA (URGN) United States $0.660B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.650B 0.00
Clovis Oncology (CLVS) United States $0.640B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.629B 0.00
Mesoblast (MESO) Australia $0.616B 0.00
Cellectis S.A (CLLS) France $0.614B 0.00
Sorrento Therapeutics (SRNE) United States $0.614B 0.00
GENFIT S.A (GNFT) France $0.606B 0.00
BioDelivery Sciences (BDSI) United States $0.605B 0.00
Cytokineticsorporated (CYTK) United States $0.578B 0.00
Retrophin (RTRX) United States $0.564B 0.00
Agenus (AGEN) United States $0.552B 0.00
PHARMA MAR SA (PHMMF) Spain $0.549B 0.00
Kadmon Holdings (KDMN) United States $0.542B 0.00
Intra-Cellular Therapies (ITCI) United States $0.537B 0.00
AC Immune SA (ACIU) Switzerland $0.535B 12.38
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.514B 0.00
Stemline Therapeutics (STML) United States $0.502B 0.00
Prothena (PRTA) Ireland $0.496B 0.00
Dynavax Technologies (DVAX) United States $0.466B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
AnaptysBio (ANAB) United States $0.388B 0.00
Merus (MRUS) Netherlands $0.387B 0.00
Bellus Health (BLU) Canada $0.384B 0.00
Arcus Biosciences (RCUS) United States $0.377B 0.00
Puma Biotechnology (PBYI) United States $0.364B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.362B 0.00
PDL BioPharma (PDLI) United States $0.354B 8.86
OSMOTICA PHARM (OSMT) United States $0.351B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.351B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.351B 2.43
Starpharma Holdings (SPHRY) Australia $0.343B 0.00
Cellular Biomedicine (CBMG) United States $0.338B 0.00
Pfenex (PFNX) United States $0.334B 0.00
Avid Bioservices (CDMO) United States $0.317B 0.00
Gritstone Oncology (GRTS) United States $0.312B 0.00
Geron (GERN) United States $0.300B 0.00
Kindred Biosciences (KIN) United States $0.299B 0.00
CytomX Therapeutics (CTMX) United States $0.288B 0.00
Kamada (KMDA) Israel $0.287B 8.38
Cue Biopharma (CUE) United States $0.276B 0.00
Compugen (CGEN) Israel $0.274B 0.00
Cel-Sci (CVM) United States $0.267B 0.00
Albireo Pharma (ALBO) United States $0.266B 0.00
Seres Therapeutics (MCRB) United States $0.263B 0.00
ADMA Biologics Inc (ADMA) United States $0.259B 0.00
Inovio Pharmaceuticals (INO) United States $0.255B 0.00
MannKind (MNKD) United States $0.254B 0.00
Scholar Rock Holding (SRRK) United States $0.246B 0.00
Exicure (XCUR) United States $0.233B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.233B 0.00
Biofrontera AG (BFRA) Germany $0.232B 0.00
Theratechnologies (THTX) Canada $0.231B 0.00
Spero Therapeutics (SPRO) United States $0.215B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.214B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
ChromaDex (CDXC) United States $0.212B 0.00
XOMA (XOMA) United States $0.208B 0.00
Athersys (ATHX) United States $0.205B 0.00
Syros Pharmaceuticals (SYRS) United States $0.203B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.200B 0.00
Mersana Therapeutics (MRSN) United States $0.194B 0.00
Senesco Technologies (ELOX) United States $0.193B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.193B 0.00
Affimed (AFMD) Germany $0.186B 0.00
Palatin Technologies (PTN) United States $0.183B 4.99
IVERIC Bio (ISEE) United States $0.172B 0.00
ARAVIVE, INC (ARAV) United States $0.169B 0.00
Dyadic (DYAI) United States $0.168B 0.00
Abeona Therapeutics (ABEO) United States $0.166B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.159B 0.00
Cerecor (CERC) United States $0.157B 0.00
CorMedix Inc (CRMD) United States $0.155B 0.00
VBI Vaccines (VBIV) United States $0.154B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.152B 0.00
Five Prime Therapeutics (FPRX) United States $0.146B 0.00
Alcobra (ARCT) United States $0.145B 0.00
TELA Bio (TELA) United States $0.143B 0.00
Fortress Biotech (FBIO) United States $0.140B 0.00
NantKwest (NK) United States $0.139B 0.00
Prometic Life Sciences (LMNL) Canada $0.137B 0.00
Proteostasis Therapeutics (PTI) United States $0.135B 0.00
Northwest Biotherapeutics (NWBO) United States $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.132B 0.00
Aptinyx (APTX) United States $0.129B 0.00
Enzo Biochem (ENZ) United States $0.129B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.129B 0.00
Protagonist Therapeutics (PTGX) United States $0.128B 0.00
Novavax (NVAX) United States $0.127B 0.00
SESEN BIO, INC (SESN) United States $0.126B 0.00
Nicox SA (NICXF) France $0.126B 0.00
Arsanis (XFOR) United States $0.126B 0.00
Celyad SA (CYAD) Belgium $0.122B 0.00
BioTime (LCTX) United States $0.120B 6.15
AVEO Pharmaceuticals (AVEO) United States $0.119B 0.00
Arbutus Biopharma (ABUS) Canada $0.114B 0.00
Verastem (VSTM) United States $0.106B 0.00
Menlo Therapeutics (MNLO) United States $0.105B 0.00
Emmaus Life Sciences (EMMA) United States $0.104B 0.00
OvaScience (MLND) United States $0.103B 0.00
PHASEBIO PHARMA (PHAS) United States $0.100B 0.00
Strongbridge Biopharma (SBBP) United States $0.099B 2.65
Acorda Therapeutics (ACOR) United States $0.099B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.099B 0.00
Aduro Biotech (ADRO) United States $0.095B 0.00
Adocia (ADOCY) France $0.086B 0.00
Antibe Therapeutics (ATBPF) Canada $0.084B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.084B 0.00
VTv Therapeutics (VTVT) United States $0.084B 0.00
Liquidia Technologies (LQDA) United States $0.079B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
Synlogic (SYBX) United States $0.076B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Selecta Biosciences (SELB) United States $0.074B 0.00
Clearside Biomedical (CLSD) United States $0.071B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Catalyst Biosciences (CBIO) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.065B 0.00
Organovo Holdings (ONVO) United States $0.064B 0.00
Trevena (TRVN) United States $0.063B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
Curis (CRIS) United States $0.059B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.055B 0.00
Idera Pharmaceuticals (IDRA) United States $0.055B 0.00
Applied Genetic Technologies (AGTC) United States $0.050B 0.00
AIT Therapeutics (XAIR) United States $0.049B 0.00
AquaBounty Technologies (AQB) United States $0.048B 0.00
Protalix BioTherapeutics (PLX) Israel $0.047B 0.00
Orgenesis (ORGS) United States $0.047B 3.03
Sunesis Pharmaceuticals (SNSS) United States $0.046B 0.00
Checkpoint Therapeutics (CKPT) United States $0.046B 0.00
Oncobiologics (OTLK) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.042B 0.00
Celldex Therapeutics (CLDX) United States $0.041B 0.00
Stellar Biotechnologies (EDSA) Canada $0.036B 0.00
Evogene (EVGN) Israel $0.035B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Celsion (CLSN) United States $0.033B 0.00
BioCardia (BCDA) United States $0.033B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.61
Aptevo Therapeutics (APVO) United States $0.029B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Entera Bio (ENTX) Israel $0.025B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
Bionano Genomics (BNGO) United States $0.025B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
Signal Genetics (MGEN) United States $0.024B 0.00
Apricus Biosciences (SEEL) United States $0.023B 0.00
Unum Therapeutics (UMRX) United States $0.023B 0.00
Soligenix (SNGX) United States $0.021B 0.00
CollPlant Holdings (CLGN) Israel $0.020B 0.00
VistaGen Therapeutics (VTGN) United States $0.018B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
Advaxis (ADXS) United States $0.010B 0.00
Cesca Therapeutics (THMO) United States $0.009B 0.00
Cleveland BioLabs (CBLI) United States $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
IBio (IBIO) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.003B 0.00